She is a gynecologic oncologist specializing in treating gynecologic malignancies with both surgical and systemic therapies. Dr. Fleming will divide her time evenly between overseeing daily operations ...
Q3 2024 OvaSuiteSM revenue of $2.3 million and volume of 6,001 units Cash utilization for the third quarter was $2.9 million, a decrease of 12% compared to the second quarter of 2024 Full year 2024 ...
Momentis Surgical Ltd., a leader in robotic-assisted surgical innovation, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for its second-generation Anovo ® robotic ...